Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal dexmedetomidine plus buccal midazolam for MRI sedation in children
ChiCTR-OPC-17013328Phase 4Recruiting
- Sponsor
- Guangzhou Women and Children's Medical Center
- Start
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of dexmedetomidine and midazolam, sponsored by Guangzhou Women and Children's Medical Center. Primary endpoint: sedation success rate. Started Nov 2017; status: recruiting.
02
Drugs
dexmedetomidinemidazolam
Beyond the preview
Go deeper on ChiCTR-OPC-17013328.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPC-17013328.